DDB-202

N/A

Report date: 2023/02/11 14:44:35

Base Information

Drug NameDDB-202
Drug Alias NameN/A
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionMyelin basic protein modulators
TargetsMyelin basic protein
Therapy Area/IndicationsMultiple Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesDyodelta Biosciences Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDyodelta Biosciences Ltd
Active IndicationsN/A
Inactive IndicationsMultiple Sclerosis

Other Information

ATC CodeN/A
Related LinksN/A